NanoString Technologies Germany GmbH

NanoString Technologies, a leader in spatial biology, offers an ecosystem of innovative discovery and translational research solutions. The company provides three platforms that allow researchers to map the universe of biology.

The GeoMx® Digital Spatial Profiler, cited in approximately 190 peer‐reviewed publications, is a flexible and consistent solution combining the power of whole tissue imaging with gene expression and protein data for spatial whole transcriptomics and proteomics from one FFPE slide. The CosMx™ Spatial Molecular Imager is an FFPE‐compatible, single‐cell imaging platform powered by spatial multiomics enabling researchers to map single cells in their native environments to extract deep biological insights and novel discoveries from one experiment. The AtoMx™ Spatial Informatics Platform is a cloud based informatics solution with advanced analytics and global collaboration capabilities, enabling powerful spatial biology insights anytime, anywhere. At the foundation of our research tools is our nCounter® Analysis System, cited in approximately 6,500 peer‐reviewed publications, which offers a secure way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision.

For more information, visit www.nanostring.com.

  • Mitarbeiterzahl

    715
  • Kategorien
    • Beratung
    • Bioanalytik
    • Diagnostika-Entwickler
    • Labormaterialien
  • Gegründet

    2003
  • Aktualisiert am

    18.07.2023

National Geographic Highlights Use of the CosMx Spatial Molecular Imager in Alzheimer’s Disease Research

Spatial Molecular Imager Locates Rare Senescent Cells in Brain Tissue


NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced that the company’s CosMx™ Spatial Molecular Imager (SMI) has been highlighted in the January edition of National Geographic Magazine. An article entitled ‘Living Longer and Better’ highlighted research from Wake Forest University, which used the CosMx SMI to study human brain tissue from patients with Alzheimer’s disease to reveal the intricacies of human aging.